How should we normalize regional volume abnormalities in childhood neurodegenerative disorders?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Efforts to understand Huntington disease (HD) have advanced neuroscience and clinical neurology as much as any human disorder and have led to improved research methods at every level of investigation, from molecular modeling to neuroimaging to population genetics. Among the vexing questions remaining in HD is why motor manifestations differ so starkly between childhood and adult HD. When HD manifests before the age of 20 (juvenile-onset, JOHD), symptoms commonly present with a hypokinetic-rigid syndrome that differs markedly from the hyperkinetic phenotype seen in adult-onset HD.1 Neuroanatomical investigations suggest more widespread deterioration of striatal projections in hypokinetic-rigid HD,2 although the pathophysiologic underpinnings of this difference in motor manifestations are unknown. Do higher CAG repeats lead to distinct molecular pathologies? Does neurodegeneration affect different regions in JOHD? Is HD and JOHD pathology identical, but manifests differently because of the shifts in receptor profile, neurotransmitter synthesis, and regional connectivity that are the hallmarks of development?
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 789
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Emily Gilmore and Dr. Rachel Beekman
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington diseaseC. Fennema-Notestine, S. L. Archibald, M. W. Jacobson et al.Neurology, September 27, 2004 -
Article
Neurofilament light protein in blood predicts regional atrophy in Huntington diseaseEileanoir B. Johnson, Lauren M. Byrne, Sarah Gregory et al.Neurology, January 24, 2018 -
Article
Brain structure in juvenile-onset Huntington diseaseAlexander Tereshchenko, Vincent Magnotta, Eric Epping et al.Neurology, April 10, 2019 -
Brief Communications
Increased rate of whole-brain atrophy over 6 months in early Huntington diseaseS.M.D. Henley, C. Frost, D. G. MacManus et al.Neurology, August 21, 2006